February 28, 2017 Uses in Waiver Clause

Waiver from Waiver

This Waiver (this "Waiver") is entered into as of January 9, 2017, by and between Great Basin Scientific, Inc., a Delaware corporation (the "Company"), and the undersigned holder (the "Holder") which is one of the investors listed on the Schedule of Buyers ("Schedule of Buyers") attached to that certain Securities Purchase Agreement between the Company and all of the investors listed on the Schedule of Buyers (the "Buyers") dated June 29, 2016 (the "SPA") with reference to the following facts:

Waiver. The Holder hereby waives, effective as of the Effective Time: (i) the breach by the Company of Sections 33(gg)(xi) and 33(gg)(xii) of the Notes solely relating to the determination of the satisfaction of the Equity Condtions with respect to the delivery of any Pre-Installment Shares and Installment Balance Shares pursuant to the terms of the Notes occurring prior to the date hereof and through February 28, 2017, (ii) the Event of Default arising under Section 4(a)(xvii) of the Notes due to the Company's failure to comply with Sections 33(gg)(xi) and 33(gg)(xii) of the Notes solely with respect to the January Accelerations (i), and (iii) the Company's obligation to comply with the Negative Covenants (Sections 17(a), 17(c), 17(d) and 17(e) of the Notes) solely in connection with the issuance of the Series G Preferred Stock, the payment of any non-cash Series G Dividends which may accrue and become payable pursuant to the terms of the Series G Preferred Stock and the accretion of such dividends to the Series G Preferred Stock. For the avoidance of doubt, the waivers contained in this Section 1 shall not apply to: (x) the payment of any cash dividends with respect to the Series G Preferred Stock and (y) the deremination of the satisfaction of the Equity Conditions with respect to the determination of whether a Control Account Release Event has occurred.

Waiver from Waiver

This Waiver (this "Waiver") is entered into as of December 2, 2016, by and between Great Basin Scientific, Inc., a Delaware corporation (the "Company"), and the undersigned holder (the "Holder") which is one of the investors listed on the Schedule of Buyers ("Schedule of Buyers") attached to that certain Securities Purchase Agreement between the Company and all of the investors listed on the Schedule of Buyers (the "Buyers") dated June 29, 2016 (the "SPA") with reference to the following facts:

Waiver. The Holder hereby waives, effective as of the Effective Time: (i) the breach by the Company of Section 4(n)(ii) of the SPA solely with respect to (x) the Company's filing of the Offering Registration Statement Amendment, (y) the Company's filing of further amendments to the Offering Registration Statement, as amended by the Offering Registration Statement Amendment, to complete the Amended Offering by no later than February 28, 2017 and (z) the Company's consummation of the Amended Offering as set forth in the Offering Registration Statement, as amended by the Offering Registration Statement Amendment and by any further amendments described in the immediately preceding clause (y), and (ii) the Event of Default arising under Section 4(a)(x) of the Notes due to the Company's failure to comply with Section 4(n)(ii) of the SPA as described in the immediately preceding clause (i).